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Bilateral simultaneous tubal pregnancy is a rare event.
Conservative treatment is the standard method to pre-
serve fertility. This report describes the use of a combina-
tion of laparoscopic salpingostomy and postoperative
prophylactic methotrexate (MTX) in a woman with
bilateral tubal pregnancy in order to preserve fertility
successfully.
A 25-year-old woman, gravida 1, para 0, abortus 1,
suffered from secondary amenorrhea combined with
intermittent vaginal bleeding and dull lower abdomi-
nal pain 1 week before she was referred to our medical
center. Her gynecologic history showed secondary infer-
tility of more than 1 year. There was no history of pelvic
inflammatory disease, intrauterine contraceptive device
use, or major pelvic surgery. Urinary pregnancy test was
positive after the second course of clomiphene citrate
(Clomid; YunHsin, Taichung, Taiwan), with 100 mg
administered orally, from days 5–9 of the menstrual cycle
at a private clinic. However, no intrauterine pregnancy
was revealed on serial ultrasonography. Serum human
chorionic gonadotropin (hCG) level showed an abnor-
mal rise (11,000 IU/L initially vs. 17,000 IU/L 4 days
after initial measurement). She was then transferred to
our tertiary center. Vaginal ultrasound scan was per-
formed, confirming the absence of a gestational sac in
the uterus and showing the presence of abdominal
fluid and a right adnexal mass measuring 3.2 × 2.8 cm.
Laparoscopic surgery was arranged under the impres-
sion of extrauterine pregnancy. In the operating room,
about 200 mL of blood was found in the cul-de-sac.
Both tubes had an ampullary pregnancy (Figure). 
A clinical diagnosis of bilateral ectopic pregnancy was
made. Laparoscopic bilateral salpingostomy with
removal of the products of conception was carried out
to preserve tubal fertility.
Prophylactic MTX (AHP Pharma, Hoofddorp, The
Netherlands) treatment is indicated, because the pre-
operative serum hCG level was more than 10,000 IU/L.
Since there was no contraindication for the use of
MTX after serial laboratory workup, prophylactic MTX
was administrated as a single dose of 1 mg/kg intra-
muscularly (total dose 50 mg), within 24 hours post-
operatively. No side effects related to MTX were noted.
The postoperative condition was uneventful. The pa-
tient was discharged as scheduled.
Serum hCG level declined to 1,105 IU/L 3 days after
the administration of MTX. Urinary pregnancy test
result was negative 3 weeks after surgery. Histologic
examination of the specimens from the bilateral tubes
confirmed the diagnosis. Spontaneous conception was
diagnosed 11 months after surgery. A normal healthy
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Figure. Unruptured bilateral tubal pregnancy, both in the
ampullary portion.
girl weighing 3,210 g was born at 39 weeks’ gestation
via normal spontaneous vaginal delivery.
Bilateral simultaneous tubal pregnancy is a rare
event. The estimated incidence of bilateral simultane-
ous tubal pregnancy is 1/200,000 of live births follow-
ing natural conception [1] and 1/725 to 1/1,580 of all
extrauterine pregnancies [2]. Kauppi-Sahla et al [3]
demonstrated the association between bilateral tubal
pregnancies and clomiphene use. Our patient had
received clomiphene citrate for ovulation induction, and
this may have resulted in multiple ovulation. Therefore,
clinicians must be alert to the possibility of bilateral
tubal pregnancy in patients who receive clomiphene
citrate. Additionally, bilateral tubal pregnancies have
been reported in natural cycles [4], after in vitro fertil-
ization [5,6], and use of an intrauterine contraceptive
device following tubal surgeries (both sterilization and
reversal of sterilization operations) [7]. Recently, the
incidence has increased, because both pelvic inflam-
matory disease and the use of assisted fertility have
become more common [8,9].
The clinical diagnosis of bilateral tubal pregnancy
is similar to unilateral ectopic pregnancy, including the
symptoms and/or signs, and the abnormal serum hCG
levels in comparison with a normal pregnancy. Like most
reported cases, our preoperative survey failed to reveal
bilateral ectopic pregnancy. The typical sonographic
findings indicative of right ectopic pregnancy failed to
alert us to the possibility of a left ectopic pregnancy,
and we did not detect the concomitant left ectopic preg-
nancy, in the presence of the abnormally high serum
hCG levels. Thus, clinicians must keep in mind the
importance of inspecting the contralateral tube at the
time of preoperative sonographic examination and
surgery in patients after the use of ovarian stimulants.
The standard treatment for unruptured unilateral
ectopic pregnancy in women who wish to preserve
their fertility includes salpingostomy and medical MTX
treatment. The literature revealed that there were no
differences between laparoscopy and medical treatment
in terms of the primary success rate, the homolateral
tubal patency rate [10], and subsequent fertility out-
comes [11]. However, laparoscopy has more advan-
tages over medical treatment. Failed primary MTX
treatment at the dose of 50 mg/m2 for unrecognized
bilateral tubal pregnancy was reported [12], and it is
proposed that the effective dosage of systemic MTX
for bilateral tubal pregnancy should be adjusted. In
addition, a definite diagnosis of bilateral tubal preg-
nancy was not made until surgery was performed.
Laparoscopy is the most common minimally invasive
surgery. Since subsequent spontaneous conception 
in women after unruptured bilateral tubal pregnancy
treated with laparoscopic salpingostomy was published,
laparoscopic conservative surgery has remained the
cornerstone of treatment [13].
Stovall et al [14] first addressed the single-dose MTX
for treatment of ectopic pregnancies in 1991. Later, this
group reported that high preoperative serum hCG levels
was significantly linked to the failure of medical treat-
ment [15]. They found that among the women with
initial serum hCG of more than 10,000 IU/L, the failure
rate was nearly 25%. They concluded that among
women with tubal ectopic pregnancies, high serum hCG
was the most important factor associated with failure
of treatment with a single-dose MTX protocol.
In addition, risk factors associated with persistent
ectopic pregnancies after conservative surgery includes
high preoperative hCG levels (> 3,000 IU/L), daily
changes of preoperative increasing hCG levels >100IU/L,
and postoperative day 7 hCG levels>1,000 IU/L [16,17].
Graczykowski and Mishell [18] demonstrated that the
prophylactic postoperative MTX regimen (a single dose
of 1 mg/kg intramuscularly, within 24 hours postoper-
ative) can be used to significantly reduce the incidence
of persistent ectopic pregnancy after linear salpingos-
tomy from 14.5% to 1.9%. Furthermore, it shortened the
postoperative follow-up period. Postoperative prophy-
lactic MTX may be recommended in high-risk cases.
A review of the literature showed that all preoperative
serum hCG levels in cases of bilateral tubal pregnancy
successfully treated with laparoscopic salpingostomy
were either less than 3,000 IU/L or not revealed. In our
case, the preoperative hCG level was more than
10,000 IU/L, and daily increases of preoperative hCG
level were more than 100 IU/L. The incidence of per-
sistent ectopic pregnancy after laparoscopic surgery
was estimated to be more than 14.5% in our case.
Thus, a single dose of prophylactic MTX (1 mg/kg)
was administrated intramuscularly in our case to pre-
serve fertility. It resulted in sequent patent unilateral
tube and spontaneous conception later.
In conclusion, laparoscopic conservative surgery is
the cornerstone of treatment in women with unrup-
tured bilateral ectopic pregnancies. In addition, a sin-
gle dose of prophylactic MTX (1 mg/kg) within 24
hours given postoperatively is recommended to pre-
serve fertility in women at high risk of developing per-
sistent ectopic pregnancies.
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